share_log

JP Morgan Maintains Overweight on Progyny, Lowers Price Target to $57

Benzinga ·  Oct 9, 2023 14:48

JP Morgan analyst Anne Samuel maintains Progyny (NASDAQ:PGNY) with a Overweight and lowers the price target from $58 to $57.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment